L'Oréal Dermatological Beauty Pro is a digital community empowering healthcare professionals to improve their daily practice of dermatology through cutting-edge research, science and education on skin and hair care.
The traditional view of allergy holds that sensitization occurs at the site of symptoms: skin allergies are triggered through skin contact, food allergies are triggered by ingesting the offending substance and respiratory allergies are triggered via inhalation. This model is strongly challenged today.
Already in 2003, a clinical study conducted in a cohort of 13,971 preschool children showed that the use of skin preparations containing peanut oil (e.g. diaper rash creams) increased the risk of peanut allergy by 6.8-fold vs no use.1
Later, studies using mouse model of allergy suggested that the skin may be a relevant source of allergen sensitization.
As it has been suggested that the skin may serve as a site for sensitization to allergens even when allergic skin inflammation is absent, it is proposed today that it may be an important site in the initiation of the atopic march.4
When this critical barrier is disrupted, allergens pass into the dermis and come in contact with the immune cells of this skin, and this contact can cause sensitization.
For reasons that are complex and not yet fully elucidated, the immune cells may overreact, treating the allergen as a harmful substance and triggering the production of allergen-reactive cells in the lymph nodes.
The strength and the integrity of the stratum corneum, as well as the cutaneous permeability regulation, are mainly driven by filaggrin (FLG). FLG null mutations are responsible of an impairment of the skin barrier function allowing antigen to penetrate and promoting water evaporation.5
They are also strongly associated with risk for atopic dermatitis (AD), for food allergies and asthma.4
Clinically speaking, increased allergy risk is linked to skin barrier impairment as showed in infants with or without clinical symptoms of atopic dermatitis but with an increased trans-epidermal water loss (TEWL), a marker of skin barrier defects.6,7
And, of course, an impaired skin barrier as it exists in atopic dermatitis increases the risk of food allergy, for example risk of peanut allergy, which incidence was found to be 2-fold higher in children with AD (incidence), and even more so when AD is severe.8
Adults can also become sensitized via the skin:
In a context where allergy prevention is shifting from allergen avoidance to tolerance, emollients could provide protection from environmental factors by improving the skin barrier function.11
Emollients provide lipids to the stratum corneum, which in turn, improves skin hydration by trapping water.11,12
This skin barrier enhancement prevents skin dryness and cracking, as well as inhibiting irritant and allergen penetration into the epidermis, which are potential initiators of skin inflammation.12
Emollients have been found to correct subclinical skin barrier dysfunction and early inflammation in predisposed infants before atopic dermatitis development by improving skin hydration and reducing skin permeability.12
This early skin protection with emollients could help slow the allergic march by preventing sensitization and associated food allergy, asthma or allergic rhinitis.13
Bibliography